Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity

1. Ketola, K.
2. Kaljunen, H.
3. Taavitsainen, S.
4. Kaarijärvi, R.
5. Järvelä, E.
6. Rodríguez-Martín, B.
7. Haase, K.
8. Woodcock, D.J.
9. Tubio, J.
10. Wedge, D.C.
11. Nykter, M.
12. Steven Bova, G.